BioAlliance Pharma http://http://www.bioalliancepharma.com/eng 13 May 2013 - BioAlliance Pharma announces DSMB second positive recommendation to continue its Phase III clinical trial with Livatag® in primary liver cancer http://http://www.bioalliancepharma.com/eng/content/download/14677/172213/version/1/file/130513_2e_DSMB_Relive_EN.pdf 15 April 2013 - BioAlliance Pharma updates on major achievements of 2012 and publishes its 2012 consolidated financial statements and income for Q1 2013 http://http://www.bioalliancepharma.com/eng/content/download/14487/170472/version/1/file/130415EN_BioAlliance_2012results_1Q1.pdf 15 April 2013 - BioAlliance Pharma's Sitavig® receives Market Authorization in the US for the treatment of Herpes Labialis http://http://www.bioalliancepharma.com/eng/content/download/14485/170466/version/1/file/041513EN_BioAlliance_Sitavig_US.pdf 12 March 2013 - BioAlliance Pharma pursues the development plan of its Loramyc® in Japan through its partner Sosei - Initiation of the pivotal registration phase III trial http://http://www.bioalliancepharma.com/eng/content/download/14298/168268/version/1/file/130312EN_Loramyc Develpt Japan.pdf 28 February 2013 - BioAlliance Pharma signs a collaborative agreement with one of the worldwide leaders in vaccines for a vaccine application of its patented Lauriad® mucoadhesive technology http://http://www.bioalliancepharma.com/eng/content/download/14178/166807/version/1/file/13022EN_Collaboration Vaccine.pdf 14 February 2013 - BioAlliance Pharma announces the forthcoming extension of its phase II clinical trial with Validive® in the United States http://http://www.bioalliancepharma.com/eng/content/download/14039/165093/version/1/file/130214EN_VALIDIVE_US.pdf 25 January 2013 - Set up of a standby equity financing (PACEO) to support the growth projects of BioAlliance Pharma http://http://www.bioalliancepharma.com/eng/content/download/13856/162857/version/1/file/130125EN_PACEO.pdf 07 January 2013 - BioAlliance Pharma announces the launch of Oravig® in the United States by its new partner, Vestiq Pharmaceuticals http://http://www.bioalliancepharma.com/eng/content/download/13677/160767/version/1/file/130107EN_OravigLaunchUS.pdf 03 January 2013 - BioAlliance Pharma receives a guarantee from Coface to finance its export activities http://http://www.bioalliancepharma.com/eng/content/download/13645/160420/version/1/file/130103EN_COFACE.pdf 19 December 2012 - BioAlliance Pharma announces the registration of Sitavig® in European countries http://http://www.bioalliancepharma.com/eng/content/download/13594/159817/version/1/file/121219EN_Sitavig AMM Europe.pdf 06 December 2012 - First meeting of the DSMB of the ReLive trial and continuation without modification of the Phase III clinical trial with Livatag® in primary liver cancer http://http://www.bioalliancepharma.com/eng/content/download/13500/158681/version/1/file/121206EN_ReLIVE_DSMB.pdf 14 November 2012 - Quarterly information as of September 30, 2012 - A dynamic progression of BioAlliance Pharma portfolio http://http://www.bioalliancepharma.com/eng/content/download/13343/156711/version/1/file/141112_EN Q3 2012.pdf 18 October 2012 - New agreement signed for the distribution of Loramyc® in Iran with Shafayab Gostar http://http://www.bioalliancepharma.com/eng/content/download/13105/153754/version/1/file/121018EN_Distribution_Iran.pdf 01 October 2012 - Presentation of Phase I clinical results with AMEP® biotherapy in the treatment of metastatic melanoma http://http://www.bioalliancepharma.com/eng/content/download/12962/151918/version/1/file/121001EN_Amep ESMO.pdf 24 September 2012 - BioAlliance Pharma announces the execution of its licensing agreement with Vestiq Pharmaceuticals for Oravig® in the US http://http://www.bioalliancepharma.com/eng/content/download/12913/151304/version/1/file/120924EN_Signature Accord Oravig.pdf 13 September 2012 - Key milestones and consolidated accounts for the first semester of 2012 http://http://www.bioalliancepharma.com/eng/content/download/12855/150592/version/1/file/120913EN_Resultats semestriels 2012.pdf 26 July 2012 - BioAlliance Pharma announces the grant of US patent covering Sitavig® http://http://www.bioalliancepharma.com/eng/content/download/12589/147640/version/1/file/120726EN_Sitavig_Brevet.pdf 19 July 2012 - BioAlliance Pharma announces a license agreement on Oravig® in the United States with Vestiq Pharmaceuticals http://http://www.bioalliancepharma.com/eng/content/download/12527/147051/version/1/file/120719EN_Oravig_US.pdf 12 July 2012 - BioAlliance Pharma extends and strengthens the protection of AMEP® with the grant of two patents in the US http://http://www.bioalliancepharma.com/eng/content/download/12493/146632/version/1/file/120712EN_Amep Brevet.pdf 02 July 2012 - Progress in the development of Loramyc® in Japan towards its registration by the partner Sosei http://http://www.bioalliancepharma.com/eng/content/download/12426/145842/version/1/file/120702EN_Loramyc Sosei.pdf